Hemant Roy to Anti-Inflammatory Agents, Non-Steroidal
This is a "connection" page, showing publications Hemant Roy has written about Anti-Inflammatory Agents, Non-Steroidal.
Connection Strength
1.082
-
Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut. 2017 02; 66(2):285-292.
Score: 0.404
-
Association of stem-like cells in gender-specific chemoprevention against intestinal neoplasia in MIN mouse. Oncol Rep. 2011 Nov; 26(5):1127-32.
Score: 0.300
-
The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits beta-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis. Cancer Lett. 2005 Jan 20; 217(2):161-9.
Score: 0.192
-
Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. Int J Cancer. 2001 May 15; 92(4):609-15.
Score: 0.148
-
Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation. Br J Cancer. 2001 May 18; 84(10):1412-6.
Score: 0.037